Aneurysm Therapeutics Market Outlook, Segments, Developments, and Insights by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Aneurysm Therapeutics Market covers analysis By Type ( Medicine, Surgery, Other Types ); End User ( Hospitals, Clinics, Other End Users ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00008955
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Aneurysm Therapeutics Market is expected to register a CAGR of 7.80% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report presents an analysis based on by Product Type ( Medicine, Surgery, Other Types ). The report further provides analysis based on End User ( Hospitals, Clinics, Other End Users ). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.

Purpose of the Report

The report Aneurysm Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Aneurysm Therapeutics Market Segmentation

Type

  • Medicine
  • Surgery
  • Other Types

End User

  • Hospitals
  • Clinics
  • Other End Users

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Aneurysm Therapeutics Market: Strategic Insights

aneurysm-therapeutics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Aneurysm Therapeutics Market Growth Drivers

  • Innovative Reflections in Healthcare Imaging Technology: Advanced imaging modalities such as high-resolution magnetic resonance imaging (MRI) and computed tomographic scans now make it possible to diagnose aneurysms earlier, surveil their growth, locate them, and measure their size so individualized treatment approaches can be formulated. Then, it follows that with the more advanced imaging technology, the more need there is to create new therapeutics, thereby driving the markets for aneurysm treatment.
  • Establishes the Growing Aging Population: The global increase in elderly individuals has contributed to an increase in such age-related diseases as aneurysms. Older people are more professionals developing an aneurysm, especially in their aorta and brain; as this population increases, the need for treatment continues, so it increases market demands for surgery- and drug-based treatments for the growing burden of aneurysms.
  • New Breakthroughs in Minimally Invasive Procedures: These techniques include endovascular repair of aneurysms (EVAR), which facilitate the development of alternatives to the classical procedure that are both safe and quicker for a patient to recover from. These techniques are characterized by smaller incisions coupled with reduced complication risks and shorter hospital stays. They keep evolving, attracting patients and health-care providers seeking efficient and less invasive approaches to therapy.

Aneurysm Therapeutics Market Future Trends

  • Personalization in Aneurysm Therapy: Treatment extricates the possible development with regards to treatment individualized according to the personal genetic profile of the patient and the injury risks. Thus, clinicians will rely more intensively on biomarker and advanced diagnostics to augment their capacity to predict better the risk of an aneurysm rupture and customize interventions. It is most likely to stimulate the invention of medications and therapies specifically intended for improved outcomes predicted by decreased therapy risks.
  • Emerging Applications of Artificial Intelligence Technology in Diagnosis: Artificial intelligence (AI) enhances the speed and efficiency by which an aneurysm can be identified, via imaging, and it improves the process of "scanning" by identifying façades that escape some, or even all, of the human experts. The synergies realize new possibilities from between advanced therapies and diagnosis to produce a revolution that improves prevention and treatment schemes and, consequently, the market on therapeutics.
  • Increased Attention Towards Endovascular Devices: There is a general shift in favor of endovascular devices such as stent grafts and coils in the treatment of an aneurysm. Such devices are minimally invasive with shorter recovery times and lower complication rates when compared to conventional open surgeries. With the fast changing technology, these methods are expected to dominate the market for aneurysm therapeutics with ongoing developments in device materials and techniques that will focus on improvement of treatment efficacy.

Aneurysm Therapeutics Market Opportunities

  • New Biological Therapies: Currently, approaches for biologic therapy, such as gene editing or stem-cell therapies, are among the most promising forms of aneurysm treatment. These methods might tend to reverse the very causative agents behind the aneurism--such as mutation and/or degenerative changes in the tissue--much more specifically and effectively than any other treatment possible through conventional means. Advance much, much more biologics for maximum outcome and reach among customers.
  • Emergence in Developing Economies: Manifold growth trends will be seen in the developing nations. Improvements in health and medical infrastructure will increase the aneurysm therapeutics market. Moreover, new diagnoses in access to care in such countries in Asia, Latin America, and Africa are beginning to attract attention to advanced techniques; hence part of those lives can be saved to create massive market opportunities for the pharmaceutical companies and device manufacturers to market affordable therapies into underserved populations as this market will increase.
  • Advancements of Drug Delivery System: Drug delivery systems that can be interfaced with the high technology like the targeted nanoparticles or those that are formulated for a sustained release can increase the potential of aneurysm therapeutics. This would facilitate drug administration directly to the site of the aneurysm so that release is controlled, thereby lowering side effects while maximizing therapeutics. It can also provide good patient adherence, which makes this an exciting area in the market for future growth.

Aneurysm Therapeutics Market Regional Insights

The regional trends and factors influencing the Aneurysm Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Aneurysm Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

aneurysm-therapeutics-market-global-geography
  • Get the Regional Specific Data for Aneurysm Therapeutics Market

Aneurysm Therapeutics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 7.80%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Medicine
  • Surgery
  • Other Types
By End User
  • Hospitals
  • Clinics
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GENERAL ELECTRIC COMPANY
  • Terumo Corporation
  • JOTEC GmbH
  • Cook
  • Lifetech Scientific
  • Lombard Medical Limited
  • Cardinal Health
  • Pfizer Inc.
  • Medtronic

  • Aneurysm Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

    The Aneurysm Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Aneurysm Therapeutics Market are:

    1. GENERAL ELECTRIC COMPANY
    2. Terumo Corporation
    3. JOTEC GmbH
    4. Cook
    5. Lifetech Scientific

    Disclaimer: The companies listed above are not ranked in any particular order.


    aneurysm-therapeutics-market-cagr

    • Get the Aneurysm Therapeutics Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Aneurysm Therapeutics Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Aneurysm Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What is the expected CAGR of the Aneurysm Therapeutics Market?

    The Aneurysm Therapeutics Market is estimated to witness a CAGR of 7.80% from 2023 to 2031

    What are the driving factors impacting the Aneurysm Therapeutics market?

    The major factors driving the Aneurysm Therapeutics market are:

    1.Increasing Prevalence of Cardiovascular Diseases

    2. Government Initiatives and Funding

    3. Improved Surgical Techniques

    Which region dominated the Aneurysm Therapeutics market in 2023?

    North America region dominated the Aneurysm Therapeutics market in 2023

    Which region higesh CAGR the Aneurysm Therapeutics market in 2023?

    Asia Pacific region dominated the Aneurysm Therapeutics market in 2023

    Which segment accounts for highest revenue in product type the Aneurysm Therapeutics market in 2023?

    The Left Ventricular Assist Devices (LVAD)
    segment accounts for highest revenue in product the Aneurysm Therapeutics market in 2023

    Which are some of the major players operating in the market?

    SynCardia Systems, Cleveland Heart, Inc., BiVACOR Inc., Abbott accounting for higesh market shares and are some of the major players operating in the market

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. GENERAL ELECTRIC COMPANY
    2. Terumo Corporation
    3. JOTEC GmbH
    4. Cook
    5. Lifetech Scientific
    6. Lombard Medical Limited
    7. Cardinal Health
    8. Pfizer Inc.
    9. Medtronic
    10. W. L. Gore & Associates
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo